Evidence map›Paper›PMID 29721483›Full record

ArticleSouth Asian journal of cancer

Practical consensus recommendations regarding the management of HER2 neu positive metastatic breast cancer.

M Basade, M Singhal, A K Rathi, M Nandi, S Minhas, C Goswami, S Shinde, P M Parikh, S Aggarwal

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in South Asian journal of cancer. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

M BasadeDepartment of Medical Oncology, Saifee Hospital, Mumbai, Maharashtra, India.
M SinghalDepartment of Medical Oncology, Indraprastha Apollo Hospital, New Delhi, India.
A K RathiDepartment of Radiation Oncology, MAMC, New Delhi, India.
M NandiDepartment of Medical Oncology, Jaypee Hospital, Noida, Uttar Pradesh, India.
S MinhasDepartment of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India.
C GoswamiDepartment of Medical Oncology, Jaypee Hospital, Noida, Uttar Pradesh, India.
S ShindeDepartment of Radiation Oncology, Medica Superspecialty Hospital, Kolkata, West Bengal, India.
P M ParikhDepartment of Oncology, Shalby Cancer and Research Institute, Mumbai, Maharashtra, India.
S AggarwalDepartment of Radiation Oncology, Medica Superspecialty Hospital, Kolkata, West Bengal, India.
Jaypee Hospital · INNethradhama Superspeciality Eye Hospital · INIndraprastha Apollo Hospitals · INSaifee Hospital · INShalby Hospitals · INSir Ganga Ram Hospital · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic breast cancer (MBC) is cancer that has spread from the breast to another part of the body or has come back in another distant location. Treatment options for MBC depend on several factors, including where the cancer has spread, the patient's overall health, and the levels of hormone receptors and HER2 in the tumour. Over-expression of HER2 is generally considered to be a negative prognostic feature because it accompanies an increase in breast cancer mortality. However, the development of agents that specifically target HER2 has improved the management of patients with these tumours.

Indexed as

Capecitabinecombination systemic therapydocetaxellapatinibpersonalized modificationpertuzumabTDM1trastuzumab

Identifiers

PMID29721483
PMCPMC5909294
OpenAlexW2798075742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.